Related Experiment Video
Updated: Apr 23, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial
G Scantamburlo1, M Hansenne2, V Geenen3
1Department of Psychiatry, Psychoneuroendocrinology Unit, University of Liège, Liège, Belgium.
Abstract:
The aim of this open trial was to assess the antidepressant/anxiolytic effects of oxytocin used as an adjunct to antidepressant in treatment-resistant depression. Fourteen patients, who have not responded to 40mg of escitalopram, received intranasal synthetic oxytocin during 4 weeks, in association with antidepressant. This is the first open trial study suggesting OT in association with escitalopram significantly reduced scores on Hamilton Depression Rating Scale.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Electroconvulsive Therapy
Antidepressant Drugs: Overview
Psychosis: Goals of Pharmacotherapy

